A Prospective Study of Nonsuppurative Complications of Streptococcal Pharyngitis

Öz Objective: Group A Streptococci (GAS) are the most important bacterial cause of pharyngitis. Antibiotic therapy canbe prescribed and failure to treat it is associated with suppurative and nonsuppurative complications. Nonsuppurativecomplications occur after a latency period of a few weeks and include acute rheumatic fever, scarlet fever, streptococcaltoxic shock syndrome, acute glomerulonephritis, and pediatric autoimmune neuropsychiatric disorder associated withgroup A streptococci. The aim of this study is to investigate the frequency of nonsuppurative complications in properlytreated children with GAS pharyngitis.Methods: We investigated the frequency of nonsuppurative complications in 1030 proven GAS pharyngitis patients between5 and 15 years old, who were properly treated by a prospective observational study. All patients diagnosed withGAS pharyngitis were followed up prospectively using a standard form for six months made by monthly phone calls.Results: All the isolates recovered from the patients were susceptible to penicillin. Twentyseven (2.6%) patients developedscarlet fever. No other nonsuppurative complications occured in our patient cohort.Conclusions: Penicillin remains the drug of choice for treatment of GAS pharyngitis. The rate of nonsuppurative co

Kaynakça

1. Martin JM, Green M. Group A streptococcus. Semin Pediatr Infect Dis 2006;17:140-148.

2. Pichichero ME, Disney FA, Green JL, et al. Comparative reliability of clinical, culture, and antigen detection methods for the diagnosis of group A beta-hemolytic streptococcal tonsillopharyngitis. Pediatr Ann 1992;21:798-805.

3. Pichichero ME. Group A streptococcal tonsillopharyngitis: cost-effective diagnosis and treatment. Ann Emerg Med 1995;25:390-403.

4. Shulman ST, Bisno AL, Clegg HW, et al. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America. Clin Infect Dis 2012;55:1279-1282.

5. Lieberman D, Shvartzman P, Korsonsky I, Lieberman D. Aetiology of respiratory tract infections: clinical assessment versus serological tests. Br J Gen Pract 2001; 51:998-1000.

6. Pichichero ME, Disney FA, Talpey WB, et al. Adverse and beneficial effects of immediate treatment of Group A betahemolytic streptococcal pharyngitis with penicillin. Pediatr Infect Dis J 1987;6:635-643.

7. Krober MS, Bass JW, Michels GN. Streptococcal pharyngitis. Placebo-controlled double-blind evaluation of clinical response to penicillin therapy. JAMA 1985;253:1271-1274.

8. Merrill B, Kelsberg G, Jankowski TA, Danis P. Clinical inquiries. What is the most effective diagnostic evaluation of streptococcal pharyngitis? J Fam Pract 2004;53:734;7-8, 40.

9. Cooper RJ, Hoffman JR, Bartlett JG, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background. Ann Emerg Med 2001;37:711-719.

10. Clinical and Laboratory Standards Institute (CLSI). Twentieth informational supplement. CLSI document M100-S20. CLSI; Wayne, PA: 2010. Performance standards for antimicrobial susceptibility testing.

11. Bisno AL, Gerber MA, Gwaltney JM, Jr., et al. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis 2002;35:113-125.

12. White CB, Bass JW, Yamada SM. Rapid latex agglutination compared with the throat culture for the detection of group A streptococcal infection. Pediatr Infect Dis 1986;5:208-212.

13. Nelson JD. The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis. Pediatr Infect Dis 1984;3:10-13.

14. Brink WR, Rammelkamp CH Jr., Denny FW, Wannamaker LW. Effect in penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitis. Am J Med 1951;10:300-308.

15. Dajani A, Taubert K, Ferrieri P, et al. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics 1995;96:758-64.

16. Carapetis JR. Rheumatic heart disease in developing countries. N Engl J Med 2007; 357:439-441.

17. Gordis L. The virtual disappearance of rheumatic fever in the United States: lessons in the rise and fall of disease. T. Duckett Jones memorial lecture. Circulation 1985;72:1155-1162.

18. Miyake CY, Gauvreau K, Tani LY, et al. Characteristics of children discharged from hospitals in the United States in 2000 with the diagnosis of acute rheumatic fever. Pediatrics 2007;120:503-508.

19. Beyazova U, Benli D, Beyazova M. Akut romatizmal ateş görülme sıklığı. Çocuk Sağ Hast Derg 1987;2:76-80.

20. Orun UA, Ceylan O, Bilici M, et al. Acute rheumatic fever in the Central Anatolia Region of Turkey: a 30-year experience in a single center. Eur J Pediatr 2012;171:361-368.

21. Shetty A, Mills C, Eggleton K. Primary care management of group A streptococcal pharyngitis in Northland. J Prim Health Care 2014;6:189-194.

22. Stetson CA, Rammelkamp CH Jr., Krause RM, Kohen RJ, Perry WD. Epidemic acute nephritis: studies on etiology, natural history and prevention. Medicine (Baltimore) 1955;34:431-450.

23. Anthony BF, Kaplan EL, Wannamaker LW, et al. Attack rates of acute nephritis after type 49 streptococcal infection of the skin and of the respiratory tract. J Clin Invest 1969;48:1697- 704.

24. Rammelkamp CH Jr., Weaver RS. Acute glomerulonephritis, the significance of the variations in the incidence of the disease. J Clin Invest 1953;32:345-358.

25 .Sagel I, Treser G, Ty A, et al. Occurrence and nature of glomerular lesions after group A streptococci infections in children. Ann Intern Med 1973;79:492-499.

26. Sarrell EM, Giveon SM. Streptococcal pharyngitis: a prospective study of compliance and complications. ISRN Pediatr 2012;2012:796389.